Literature DB >> 3115287

Efficacy of antiprostaglandin therapy in vernal conjunctivitis.

E Meyer1, E Kraus, S Zonis.   

Abstract

Twenty-seven patients with vernal conjunctivitis who remained symptomatic following treatment with corticosteroid drops and/or Opticrom drops (sodium cromoglycate 2%, benzalkonium chloride 0.01%) were treated with aspirin. Aspirin produced marked improvement in all patients apart from three. The possible mechanism of the efficacy of aspirin in vernal conjunctivitis is discussed.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3115287      PMCID： PMC1041213          DOI： 10.1136/bjo.71.7.497

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  8 in total

1.  A review of four hundred cases of vernal conjunctivitis.

Authors:  E NEUMANN; M J GUTMANN; N BLUMENKRANTZ; I C MICHAELSON
Journal:  Am J Ophthalmol       Date:  1959-02       Impact factor: 5.258

2.  Inhibition of the ocular effects of sodium arachidonate by anti-inflammatory compounds.

Authors:  P Bhattacherjee; K E Eakins
Journal:  Prostaglandins       Date:  1975-02

3.  Differential inflammatory effects of arachidonic acid on rabbit conjunctiva and iris: a possible role of lipoxygenase in the conjunctival response.

Authors:  P Bhattacherjee; P S Kulkarni; K E Eakins
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

4.  Disodium cromoglycate (Intal) in the treatment of vernal kerato-conjunctivitis.

Authors:  D Easty; N S Rice; B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1971

5.  Mast cell ultrastructure. Comparison in contact lens-associated giant papillary conjunctivitis and vernal conjunctivitis.

Authors:  A S Henriquez; K R Kenyon; M R Allansmith
Journal:  Arch Ophthalmol       Date:  1981-07

6.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

7.  Cromolyn effects on vernal keratoconjunctivitis in children.

Authors:  K F Tabbara; N T Arafat
Journal:  Arch Ophthalmol       Date:  1977-12

8.  Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis.

Authors:  M El Hennawi
Journal:  Br J Ophthalmol       Date:  1980-07       Impact factor: 4.638
  8 in total
  3 in total

Review 1.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

2.  Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin.

Authors:  H Nathan; N Naveh; E Meyer
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach.

Authors:  Daniele Giovanni Ghiglioni; Piera Anna Martino; Gaia Bruschi; Davide Vitali; Silvia Osnaghi; Maria Grazia Corti; Giangiacomo Beretta
Journal:  Pharmaceutics       Date:  2020-04-20       Impact factor: 6.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.